ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

ASCO Names Stratetic Planning Committee

September 23, 1988

FDA to refer false statements by regulated companies to SEC.

February 27, 2004

Horvitz Wins BMS Award In Neuroscience; Group Room To Discuss Congressional Issues.

February 22, 2002

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

June 20, 1986

Crout, Finkel Replaced at FDA; Hayes Combine Biologics, Drugs

April 2, 1982

Reports On AACR Scientific Sessions

May 21, 1976